Researchers have assembled and studied more than 25,000 anonymized interactions from a support line for people seeking help during or after psychedelic experiences, creating what the study’s authors describe as the largest dataset of psychedelic support interactions yet assembled.
The database, published in Science Advances, draws on 25,419 interactions involving 220 hotline volunteers between April 2021 and February 2026. It offers a rare view of psychedelic use outside tightly controlled clinical studies, where participants are selected in advance and experiences occur under structured conditions.
A view beyond the clinical setting
Interest in psychedelics has grown in both recreational and medical contexts. Yet much of the available research has come from clinical environments that do not necessarily resemble the settings in which many people use these substances. Outside trials, people may take psychedelics at home, at festivals, in ceremonial gatherings or in other uncontrolled environments.
That gap matters because clinical studies are designed to answer specific questions under carefully managed conditions. They can be valuable for evaluating safety and therapeutic potential, but they do not capture every circumstance that may arise when substances are used in the broader world.
The new collection of interactions comes from the Fireside Project, a nonprofit founded in 2020. Its Psychedelic Support Line connects people seeking information or support during difficult experiences with trained volunteers. Volunteers provide confidential peer support, including talking people through an experience and, in the most urgent cases, connecting callers with emergency services.
Researchers say the material provides a substantially larger source of real-world accounts than previous published psychedelic clinical trials combined. The scale does not make it equivalent to a controlled trial, nor does it establish the frequency of particular outcomes among all users. It does, however, document why a large group of people contacted a support service and the circumstances in which they did so.
More than a single type of interaction
The dataset includes phone calls and text exchanges. People contacted the line while experiencing the effects of a drug, after an experience, or when seeking information. That range is important because psychedelic support is not limited to an acute crisis; people may also seek help making sense of an experience after it has ended.
According to the reported analysis, 40.2% of the interactions—10,208 in total—involved callers who were actively tripping. Another 32.1% occurred after the experience, in a period often referred to as integration. The remaining interactions therefore covered other reasons for contacting the service, including requests for information or support not captured by those two groups.
The records encompass experiences involving psilocybin, ketamine, MDMA, LSD and ayahuasca. They also include cannabis, which is not generally classified as a psychedelic but can produce related effects such as mild hallucinations. Bringing these accounts together may allow researchers to examine how support needs differ across substances and contexts, while preserving the anonymity of the people who sought help.
Why this evidence is different
The existence of a large dataset should not be mistaken for a broad population survey. The people represented in it chose to contact a support line, which means their experiences and concerns may differ from those of people who never seek assistance. The information also reflects conversations with peer-support volunteers rather than medical diagnoses or controlled measurements.
Those limitations are part of what makes the resource distinct. Instead of asking what happens in a selected clinical cohort, it captures interactions from people who decided, in the course of their own lives, that they wanted help. That can illuminate situations that may be underrepresented in clinical research without replacing the standards and safeguards of clinical work.
Félix Schoeller, a senior research scientist at the Institute for Advanced Consciousness Studies and lead author of the study, characterized the data as an unusually rich resource for understanding psychedelic experiences outside formal medical settings. The work also reflects a wider scientific challenge: how to study substances that are being used in many settings while maintaining rigorous methods and protecting participants’ privacy.
Support data and public-health questions
The study arrives as public discussion of psychedelics often focuses on two very different narratives: potential therapeutic uses on one hand, and recreational use or adverse experiences on the other. A support-line dataset does not settle that debate. It can instead add descriptive evidence about the questions, problems and timing that lead people to seek help.
The presence of trained volunteers and emergency referrals is also a reminder that peer support has a defined role but clear limits. Some interactions can be handled through conversation and grounding support; the most urgent situations may require connection to emergency services. The source material does not support treating the line as a substitute for professional medical care.
For researchers, the database may help broaden the evidence base beyond formal treatment studies. For the public, it offers a more grounded picture of how often support may be sought during an experience versus afterward. And for policymakers and health systems, it points to a practical question likely to grow with public interest in psychedelics: what kinds of support are available when experiences occur outside a clinic?
An early foundation for further research
The value of the collection will depend on how carefully it is interpreted and whether future studies build on it with appropriate safeguards. Its strength is scale and real-world context. Its limitations are those of observational support-line data: it cannot independently determine cause, clinical effectiveness or prevalence across all psychedelic users.
Still, the 25,419 anonymized interactions make this a notable addition to the field. They provide a structured record of requests for help that were previously difficult to study at anything close to this size. As psychedelic research moves beyond a narrow set of clinical questions, data from voluntary support services could become one useful part of a broader evidence base.
This article is based on reporting by 404 Media. Read the original article.
Originally published on 404media.co
